Latest News

16 July 2018

ABC Radio National – Catriona Bradshaw discusses the success of Resistance Guided Therapy for treating M. genitalium

In her interview with Dr Norman Swan on ABC Radio National Health Report, Dr. Bradshaw discusses a new successful treatment...

Read More

12 July 2018

UK BASHH M. genitalium guidelines updated to include macrolide resistance testing

Important updates to the UK BASHH M. genitalium management guidelines are taking the issue of antimicrobial resistance (AMR) seriously. The...

Read More

21 June 2018

Clinical data demonstrates significantly increased cure rates using Resistance Guided Therapy for treating the STI Superbug M. genitalium

SpeeDx ResistancePlus® MG test supports new STI management guidelines SpeeDx Pty. Ltd. today announced clinical data contained in a new study...

Read More

23 April 2018

SpeeDx and Serosep sign UK and Ireland distribution agreement

SpeeDx has announced a distribution agreement with Serosep Ltd, a leading manufacturer and distributor of laboratory diagnostic solutions. This will...

Read More

19 April 2018

SpeeDx receives FDA listing for Mycoplasma genitalium product

SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale...

Read More

23 March 2018

Updated guidelines for M. genitalium recommend resistance testing

The Australian STI management guidelines have been updated and now suggest when testing for Mycoplasma genitalium that inclusion of macrolide...

Read More